4-丙基-1,2-苯二胺 | 346001-28-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-丙基-1,2-苯二胺
• 英文名称: 4-propyl-o-phenylenediamine
• 英文别名: 4-Propyl-o-phenylendiamin；1,2-diamino-4-n-propyl benzene；5-n-propyl-1,2-phenylenediamine；4-Propylbenzene-1,2-diamine
• CAS: 346001-28-3
• 化学式: C₉H₁₄N₂
• 分子量: 150.224
• InChiKey: ZPZZLBVKKPQYAK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  52
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 海关编码：
  2921590090

反应信息

• 作为反应物：
  描述：

  光气 、 4-丙基-1,2-苯二胺 在 盐酸 作用下， 生成 5-丙基-1,3-二氢-2H-苯并咪唑-2-酮
  参考文献：
  名称：

  Synthesis of Some Substituted Benzoxazolones

  摘要：

  DOI：

  10.1021/ja01540a038
• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 palladium on activated charcoal 、 乙醇 作用下， 生成 4-丙基-1,2-苯二胺
  参考文献：
  名称：

  Synthesis of Some Substituted Benzoxazolones

  摘要：

  DOI：

  10.1021/ja01540a038

文献信息

• [EN] NOVEL ESTROGEN RECEPTOR LIGANDS<br/>[FR] NOUVEAUX LIGANDS POUR RÉCEPTEURS D'OESTROGÈNES
  申请人：KAROBIO AB

  公开号：WO2013017654A1

  公开（公告）日：2013-02-07

  Compounds of formula (I) or a pharmaceutically acceptable ester, amide, carbamate or salt thereof, including a salt of such an ester, amide or carbamate in which R1 to R9 have meanings as defined in the Specification, are useful as estrogen receptor ligands.

  公式（I）的化合物或其药用可接受的酯、酰胺、碳酸酯或盐，包括具有规范中定义的含义的R1至R9的盐的酯、酰胺或碳酸酯，可用作雌激素受体配体。
• Benzimidazoles
  申请人：Edwards L. Michael

  公开号：US20060014756A1

  公开（公告）日：2006-01-19

  The invention is directed to physiologically active compounds of the general formula (Ix) and compositions containing such compounds, and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs, as well as to novel compounds within the scope of formula (Ix), and to processes for their preparation. Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit kinases.

  本发明涉及一般式（Ix）的生理活性化合物及含有这种化合物的组合物，以及它们的前药、药学上可接受的盐和溶剂化物，还涉及在式（Ix）范围内的新化合物和它们的制备方法。这种化合物和组合物具有有价值的药物性质，特别是抑制激酶的能力。
• METHOD AND COMPOSITIONS FOR BIOFOULING DETERRENCE
  申请人：Mount Andrew S.

  公开号：US20110123477A1

  公开（公告）日：2011-05-26

  A method of deterring biofouling of a surface comprising attaching an adduct having formula (I) or noradrenalin to the surface. Formula (I) being defined as compounds that have the formula A-L-R wherein A is i) a C6 or C10 substituted aryl ring, or ii) a C1-C9 substituted or unsubstituted heteroaryl ring: L is a linking group, and R is a primary amino moiety comprising unit.

  一种防止生物污垢的方法，包括将具有公式（I）或去甲肾上腺素的加合物附着到表面上。公式（I）被定义为具有公式A-L-R的化合物，其中A是i）C6或C10取代的芳基环，或ii）C1-C9取代或未取代的杂环；L是连接基团，R是包含单元的一级氨基团。
• [EN] PYRAZOLE-OXAZOLIDINONE COMPOUND FOR ANTI-HEPATITIS B VIRUS<br/>[FR] COMPOSÉ PYRAZOLE-OXAZOLIDINONE POUR LUTTER CONTRE LE VIRUS DE L'HÉPATITE B<br/>[ZH] 抗乙肝病毒的吡唑-噁唑烷酮类化合物
  申请人：CHEN HUANMING

  公开号：WO2017173999A1

  公开（公告）日：2017-10-12

  本发明公开了一类具有抗乙肝病毒活性的吡唑-噁唑烷酮化合物，其具有式（I）的结构，其中各变量如本文所定义。
• Synthesis and Evaluation of Terbenzimidazoles as Topoisomerase I Inhibitors
  作者：Qun Sun、Barbara Gatto、Chiang Yu、Angela Liu、Leroy F. Liu、Edmond J. LaVoie

  DOI：10.1021/jm00018a024

  日期：1995.9

  The synthesis and pharmacological activity of a series of terbenzimidazoles are described. The ability of these derivatives to induce DNA cleavage in the presence of topoisomerase I was evaluated in vitro. These analogs were also assayed for their cytotoxicity in RPMI 8402 cells and the camptothecin-resistant CPT-K5 cells. In addition the potential for these compounds to serve as substrates for MDR1 was also determined. Several terbenzimidazoles exhibited similar cytotoxicity against variants of human tumor cells that either overexpress MDR1 or are camptothecin-resistant.